lidoflazine has been researched along with Arteriosclerosis in 2 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lehmann, HU | 1 |
| Hochrein, H | 1 |
| Dvorák, I | 1 |
| Zemánková, J | 1 |
| Soják, K | 1 |
2 trials available for lidoflazine and Arteriosclerosis
| Article | Year |
|---|---|
[Antiarrhythmic properties of lidoflazine in the therapy of auricular fibrillation and flutter (clinical studies of 26 patients)].
Topics: Aged; Arteriosclerosis; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Electrocardio | 1975 |
[Results of treatment of a coronary pain syndrome with lidoflazine].
Topics: Angina Pectoris; Arteriosclerosis; Clinical Trials as Topic; Humans; Lidoflazine; Middle Aged; Piper | 1973 |